TP53 and pancreatic ductal adenocarcinoma: Moreover, a recent study showed that TP53 loss of heterozygosity (LOH) results in genomic instability, which leads to chromosome 13 loss, along with other CNAs, during the progression of pancreatic ductal adenocarcinoma [66].